Navigation Links
Probiotic Action Explains the New Link Between Probiotics, Bacteria and Eczema
Date:5/13/2013

Miami, FL (PRWEB) May 13, 2013

A recent study from the Archive of Dermatology released information on a study in which expectant mothers and infants were given probiotics and other supplements to see if it would lessen the potential for eczema, and help symptoms of the skin condition. Of the 6859 participants who received supplements 11 of 17 were able to prevent eczema, while 5 out of 6 were able to effectively treat it supplements. While the study did not fully disclose which supplements or combination of were most effective, many believe the use of probiotics lead to improved results.

Probiotic Action spokesman, Fernando Perez commented on the link between eczema, bacteria, and probiotics, “Many physicians are finding that in growing bodies, maintaining a balance of flora in the intestines can help treat and prevent many illnesses. For skin conditions that involve bacteria as a cause, probiotics and prebiotics are known to dramatically help balance the levels of good and bad bacteria that cause flare ups and irritation.”

Bacteria is often the main cause of skin conditions and irritation, for those suffering from eczema or acne, bad bacteria may make the conditions worse by creating inflammation and infections. For those who have bacteria driven skin conditions, using a probiotic as an acne treatment, or eczema treatment may not only be the best acne treatment, but may reduce some symptoms.

Perez continued to add that taking daily supplements with the right mix of vitamins and probiotics to help balance the body is often the best acne treatment as well. For those who suffer from eczema, Probiotic action recommends trying a topical probiotic or pr
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. New Tests May Help Determine Whether or Not You are More Prone to Acne Causing Bacteria, Probiotic Action Explains
2. Probiotic Action Shares New Insight on the Link Between Sugar, Probiotics, and Acne
3. Probiotic Action Comments on the New Use of Probiotics for Oral Health and Shares New Insight What It Means for the Growing US Probiotic Market
4. Probiotic Action shares New Insight on How to Care for Skin in Hot Climates
5. Probiotic Action Shares 5 New Tips for Acne Sufferers To Protect their Skin this Summer
6. Probiotic Action Shares New Insight on Why Old Makeup May Be Causing Acne
7. Probiotic Action Shares Insight for Parents on How to Treat Pre-Teen Acne without Chemicals
8. Probiotic Action Shares New Tips to Limit the side effects of Rosacea
9. Probiotic Action Announces the Use of Their Acne Treatment for All types of Skin
10. Future of Pre- and Probiotics to be Discussed by Kibow Biotech Founder During SupplySide MarketPlace 2013 Global Expo & Conference
11. Adult Acne Treatment, Probiotic Action Introduces their Antibiotic-Free Acne Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... and TORONTO , June 2, ... TSX: APS), a clinical-stage company developing new therapeutics that ... the U.S. Food and Drug Administration (FDA) has granted ... treatment of acute myeloid leukemia (AML). APTO-253, a first-in-class ... product candidate in a Phase Ib clinical trial in ...
(Date:6/2/2015)... June 02, 2015 Research and Markets( http://www.researchandmarkets.com/research/2b7734/molecular ... Diagnostics - Global Market Size, Strategy and Forecasts - ... "Molecular Diagnostics - Global Market Size, Strategy and ... and planners can use. Hundreds of pages of information ... Medicare Fee Payment Schedules to help understand test pricing ...
(Date:6/2/2015)... June 02, 2015 Cirrascale ... blade-based and rackmount computing and storage infrastructure for ... launch of its high density scale-out, two-in-one video ... Slipstream™ RM1622D . The high density, two-in-one system ... product family with Intel® Iris™ Pro graphics P6300 ...
(Date:6/2/2015)... , June 2, 2015   BioClinica ® ... technology provider, today announced that David Peters , ... named Executive Vice President and Chief Financial Officer (CFO) ... Peters brings more than 25 years of ... services. "David has extensive and deep knowledge in all ...
Breaking Biology Technology:Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Global Molecular Diagnostics Report 2015-2019 - Market Size, Strategy and Forecasts 2Global Molecular Diagnostics Report 2015-2019 - Market Size, Strategy and Forecasts 3Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3BioClinica Names David Peters New Chief Financial Officer 2
... demand for low-cost, small-size, high-speed, highly functional and ... 60 GHz radio chipsets in semiconductor technology have ... circuit board solutions are not able to meet ... 64 GHz frequency band, while the conventional antenna ...
... BSX ) today announced financial results for the third,quarter ... sales and,earnings per share (EPS) for the fourth quarter of ... sales of $1.978 billion and adjusted EPS of $0.16 ... Achieved worldwide cardiac rhythm management (CRM) sales growth of 11 ...
... percentage comparisons are to comparable periods in,2007):, -- Q3 2008 ... increased 7.4% to $540.6 million. Currency added 3.1% to organic ... 7.0% for the Company,s Research-based sales units was ... six months of 2008. Q3 2008 currency adjusted sales for SAFC ...
Cached Biology Technology:NTU and SIMTech announce the first antenna-in-package solution for single-chip 60 GHz radio 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 5Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 6Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 7Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 8Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 9Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 10Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 11Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 12Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 13Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 14Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 15Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 16Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 17Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 18Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 19Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 20Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 21Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 22Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 23Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 24Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 25Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 26Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 27Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 2Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 3Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 4Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 5Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 6Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 7Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 8Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares. 9
(Date:5/20/2015)... 20, 2015 ... announced the addition of the  "5-year ... Recognition Market"  report to their offering.  ... service analyses trends in the iris ... commercial sectors, globally. Despite hardware pricing ...
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/11/2015)... , May 11, 2015  Synaptics Incorporated ... human interface solutions, today announced the appointment of ... and Chief Financial Officer, reporting to Rick ... Synaptics, current Chief Financial Officer, Kathleen Bayless ... Mr. Ali brings extensive financial ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... Sequencing Center at Washington University School of Medicine increased ... additional Genome Sequencer FLX Systems from Roche Diagnostics. ... the Genome Sequencing Center will be able to support ... technology, ranging from the sequencing of new complex genomes ...
... of new genome sequencing technology has prompted a ... hypothesis about how agricultures early beginnings may have ... Vinatzer, assistant professor of plant pathology, physiology, and ... Life Sciences, has received a $1 million, five-year ...
... the New York-based Doris Duke Charitable Foundation (DDCF), Carnegie ... of investigators from Carnegie Mellon, the University of Minnesota, ... law firm Van Ness Feldman to develop and promote ... transport and deep geological sequestration of carbon dioxide (CO ...
Cached Biology News:Washington University increases fleet of Roche Genome Sequencer FLX Systems 2Washington University increases fleet of Roche Genome Sequencer FLX Systems 3Tomato pathogen genome may offer clues about bacterial evolution at dawn of agriculture 2Carnegie Mellon receives $1.85 million 2
... 50mM Tris-HCl, pH 7.5, 0.1mM ... 1mM benzamidine, 0.1% 2-mercaptoethanol and ... Phosphatase 2A1) partially purified enzyme ... QSepharose,amino-hexyl agarose, Superdex 200, and ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
...
... : Recombinant human HMGN2/HMG-17 Formulation: ... 0.15M NaCl, 0.05% sodium azide ... to 30% Quality Assurance: routinely ... extracts of murine 10T 1/2 ...
Biology Products: